425 related articles for article (PubMed ID: 31662286)
1. TIPS for management of portal-hypertension-related complications in patients with cirrhosis.
Allaire M; Walter A; Sutter O; Nahon P; Ganne-Carrié N; Amathieu R; Nault JC
Clin Res Hepatol Gastroenterol; 2020 Jun; 44(3):249-263. PubMed ID: 31662286
[TBL] [Abstract][Full Text] [Related]
2. The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension.
Colombato L
J Clin Gastroenterol; 2007; 41 Suppl 3():S344-51. PubMed ID: 17975487
[TBL] [Abstract][Full Text] [Related]
3. Transjugular intrahepatic portosystemic shunt in patients with cirrhosis: Indications and posttransjugular intrahepatic portosystemic shunt complications in 2020.
Horhat A; Bureau C; Thabut D; Rudler M
United European Gastroenterol J; 2021 Mar; 9(2):203-208. PubMed ID: 32819214
[TBL] [Abstract][Full Text] [Related]
4. Transjugular intrahepatic portosystemic shunts and portal hypertension-related complications.
Siramolpiwat S
World J Gastroenterol; 2014 Dec; 20(45):16996-7010. PubMed ID: 25493012
[TBL] [Abstract][Full Text] [Related]
5. Long-term effects and complications of the transjugular intrahepatic portosystemic shunt: a single-centre experience.
Kraglund F; Jepsen P; Amanavicius N; Aagaard NK
Scand J Gastroenterol; 2019 Jul; 54(7):899-904. PubMed ID: 31203699
[No Abstract] [Full Text] [Related]
6. Early TIPS with covered stents versus standard treatment for acute variceal bleeding in patients with advanced cirrhosis: a randomised controlled trial.
Lv Y; Yang Z; Liu L; Li K; He C; Wang Z; Bai W; Guo W; Yu T; Yuan X; Zhang H; Xie H; Yao L; Wang J; Li T; Wang Q; Chen H; Wang E; Xia D; Luo B; Li X; Yuan J; Han N; Zhu Y; Niu J; Cai H; Xia J; Yin Z; Wu K; Fan D; Han G;
Lancet Gastroenterol Hepatol; 2019 Aug; 4(8):587-598. PubMed ID: 31153882
[TBL] [Abstract][Full Text] [Related]
7. Early and long-term clinical and radiological follow-up results of expanded-polytetrafluoroethylene-covered stent-grafts for transjugular intrahepatic portosystemic shunt procedures.
Maleux G; Nevens F; Wilmer A; Heye S; Verslype C; Thijs M; Wilms G
Eur Radiol; 2004 Oct; 14(10):1842-50. PubMed ID: 15221261
[TBL] [Abstract][Full Text] [Related]
8. Long-term clinical outcome and survival predictors in patients with cirrhosis after 10-mm-covered transjugular intrahepatic portosystemic shunt.
Tejedor-Tejada J; Fuentes-Valenzuela E; García-Pajares F; Nájera-Muñoz R; Almohalla-Álvarez C; Sánchez-Martín F; Calero-Aguilar H; Villacastín-Ruiz E; Pintado-Garrido R; Sánchez-Antolín G
Gastroenterol Hepatol; 2021 Nov; 44(9):620-627. PubMed ID: 33249114
[TBL] [Abstract][Full Text] [Related]
9. Morbidity and mortality after transjugular intrahepatic portosystemic shunt placement in patients with cirrhosis.
Dissegna D; Sponza M; Falleti E; Fabris C; Vit A; Angeli P; Piano S; Cussigh A; Cmet S; Toniutto P
Eur J Gastroenterol Hepatol; 2019 May; 31(5):626-632. PubMed ID: 30550458
[TBL] [Abstract][Full Text] [Related]
10. Transjugular intrahepatic portosystemic shunt. Experiences at a liver transplantation center.
Hidajat N; Vogl T; Stobbe H; Schmidt J; Wex C; Lenzen R; Berg T; Neuhaus P; Felix R
Acta Radiol; 2000 Sep; 41(5):474-8. PubMed ID: 11016769
[TBL] [Abstract][Full Text] [Related]
11. Transjugular intrahepatic portosystemic shunt in cirrhosis: An exhaustive critical update.
Rajesh S; George T; Philips CA; Ahamed R; Kumbar S; Mohan N; Mohanan M; Augustine P
World J Gastroenterol; 2020 Oct; 26(37):5561-5596. PubMed ID: 33088154
[TBL] [Abstract][Full Text] [Related]
12. Role of Transjugular Intrahepatic Portosystemic Shunt in the Management of Portal Hypertension: Review and Update of the Literature.
Hung ML; Lee EW
Clin Liver Dis; 2019 Nov; 23(4):737-754. PubMed ID: 31563220
[TBL] [Abstract][Full Text] [Related]
13. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
Testino G; Ferro C; Sumberaz A; Messa P; Morelli N; Guadagni B; Ardizzone G; Valente U
Hepatogastroenterology; 2003; 50(54):1753-5. PubMed ID: 14696397
[TBL] [Abstract][Full Text] [Related]
14. Transjugular Intrahepatic Portosystemic Shunt (TIPS): Pathophysiologic Basics, Actual Indications and Results with Review of the Literature.
Strunk H; Marinova M
Rofo; 2018 Aug; 190(8):701-711. PubMed ID: 30045395
[TBL] [Abstract][Full Text] [Related]
15. Targeted puncture of left branch of intrahepatic portal vein in transjugular intrahepatic portosystemic shunt to reduce hepatic encephalopathy.
Luo SH; Chu JG; Huang H; Zhao GR; Yao KC
World J Gastroenterol; 2019 Mar; 25(9):1088-1099. PubMed ID: 30862997
[TBL] [Abstract][Full Text] [Related]
16. [TIPS - Transjugular intrahepatic portosystemic shunt. A review].
Carreiro G; da Luz Moreira A; Murad FF; Azevedo F; Coelho HS
Arq Gastroenterol; 2001; 38(1):69-80. PubMed ID: 11586999
[TBL] [Abstract][Full Text] [Related]
17. Transjugular intrahepatic portal shunt in the treatment of portal hypertension due to cirrhosis: single center experience.
Chen Y; Qiu H; Zhang X
BMC Surg; 2019 Dec; 19(1):191. PubMed ID: 31830972
[TBL] [Abstract][Full Text] [Related]
18. [Transjugular intrahepatic portosystemic shunt (TIPS) for the treatment of complications of portal hypertension in patients with liver cirrhosis].
Grønbaek H; Astrup LB; Nielsen DT; Vilstrup H
Ugeskr Laeger; 2003 Jan; 165(5):439-42. PubMed ID: 12599838
[TBL] [Abstract][Full Text] [Related]
19. Evolving Indications for Tips.
Smith M; Durham J
Tech Vasc Interv Radiol; 2016 Mar; 19(1):36-41. PubMed ID: 26997087
[TBL] [Abstract][Full Text] [Related]
20. The transjugular intrahepatic portosystemic shunt in the treatment of portal hypertension.
Hassoun Z; Pomier-Layrargues G
Eur J Gastroenterol Hepatol; 2004 Jan; 16(1):1-4. PubMed ID: 15095845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]